Microgravity is known to alter the muscles, bones, the immune system and cogni­tion, but little is known about its specific impact on the brain.

The FastGlioma tool could enable rapid and accurate detection of microscopic tumour infiltration, improving the success of ...

The addition of atezolizumab to neoadjuvant chemotherapy failed to significantly improve event-free survival in patients with ...

A recent University of Kentucky Markey Cancer Center study highlights a radiation therapy technique that treats brain tumors ...

Dr Michelle Melisko discusses the challenging aspects involved in decision-making around screening for brain metastasis in ...

Cancer is one of the most formidable health challenges of our time, affecting nearly half of us during our lives. While treatments have significantly improved in recent decades, the biggest challenge ...

Recent cancer treatment breakthroughs include FDA approvals for zenocutuzumab and durvalumab, and sacituzumab tirumotecan gained breakthrough therapy status. In addition, sonodynamic therapy shows ...

Researchers have developed a method to program immune cells to target glioblastoma and reduce inflammation associated with ...

Researchers presented data from trials of HER2-targeted therapies from Jiangsu Hengrui Medicine, Jazz Pharma, Roche, and RemeGen.

Kazia Therapeutics ( (KZIA) ) has provided an announcement.

Median overall survival (OS) to date of 13.4 months for Phase 2 patients treated with the Phase 3 formulation (15.6 months for those treated ...

Gratitude is actively practiced, even amidst personal losses and living with metastatic cancer, highlighting its importance ...